Global Anti-Tuberculosis Drug Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Anti-Tuberculosis Drug market size was valued at US$ million in 2023. With growing demand in downstream market, the Anti-Tuberculosis Drug is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Anti-Tuberculosis Drug market. Anti-Tuberculosis Drug are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Anti-Tuberculosis Drug. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Anti-Tuberculosis Drug market.
Tuberculosis is a chronic wasting infectious disease caused by Mycobacterium tuberculosis. The drugs used to treat this disease are anti-tuberculosis drugs.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Anti-Tuberculosis Drug market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Anti-Tuberculosis Drug market. It may include historical data, market segmentation by Type (e.g., First-Line Anti-Tuberculosis Drugs, Second-Line Anti-Tuberculosis Drugs), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Anti-Tuberculosis Drug market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Anti-Tuberculosis Drug market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Anti-Tuberculosis Drug industry. This include advancements in Anti-Tuberculosis Drug technology, Anti-Tuberculosis Drug new entrants, Anti-Tuberculosis Drug new investment, and other innovations that are shaping the future of Anti-Tuberculosis Drug.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Anti-Tuberculosis Drug market. It includes factors influencing customer ' purchasing decisions, preferences for Anti-Tuberculosis Drug product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Anti-Tuberculosis Drug market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Anti-Tuberculosis Drug market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Anti-Tuberculosis Drug market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Anti-Tuberculosis Drug industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Anti-Tuberculosis Drug market.
Market Segmentation:
Anti-Tuberculosis Drug market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Anti-Tuberculosis Drug market?
What factors are driving Anti-Tuberculosis Drug market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Anti-Tuberculosis Drug market opportunities vary by end market size?
How does Anti-Tuberculosis Drug break out type, application?
According to our LPI (LP Information) latest study, the global Anti-Tuberculosis Drug market size was valued at US$ million in 2023. With growing demand in downstream market, the Anti-Tuberculosis Drug is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Anti-Tuberculosis Drug market. Anti-Tuberculosis Drug are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Anti-Tuberculosis Drug. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Anti-Tuberculosis Drug market.
Tuberculosis is a chronic wasting infectious disease caused by Mycobacterium tuberculosis. The drugs used to treat this disease are anti-tuberculosis drugs.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Anti-Tuberculosis Drug market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Anti-Tuberculosis Drug market. It may include historical data, market segmentation by Type (e.g., First-Line Anti-Tuberculosis Drugs, Second-Line Anti-Tuberculosis Drugs), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Anti-Tuberculosis Drug market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Anti-Tuberculosis Drug market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Anti-Tuberculosis Drug industry. This include advancements in Anti-Tuberculosis Drug technology, Anti-Tuberculosis Drug new entrants, Anti-Tuberculosis Drug new investment, and other innovations that are shaping the future of Anti-Tuberculosis Drug.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Anti-Tuberculosis Drug market. It includes factors influencing customer ' purchasing decisions, preferences for Anti-Tuberculosis Drug product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Anti-Tuberculosis Drug market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Anti-Tuberculosis Drug market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Anti-Tuberculosis Drug market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Anti-Tuberculosis Drug industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Anti-Tuberculosis Drug market.
Market Segmentation:
Anti-Tuberculosis Drug market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- First-Line Anti-Tuberculosis Drugs
- Second-Line Anti-Tuberculosis Drugs
- Hospital
- Clinic
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Lupin
- Otsuka
- Sanofi
- Prizer
- Abbott
- NOVARTIS
What is the 10-year outlook for the global Anti-Tuberculosis Drug market?
What factors are driving Anti-Tuberculosis Drug market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Anti-Tuberculosis Drug market opportunities vary by end market size?
How does Anti-Tuberculosis Drug break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Anti-Tuberculosis Drug Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Anti-Tuberculosis Drug by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Anti-Tuberculosis Drug by Country/Region, 2019, 2023 & 2030
2.2 Anti-Tuberculosis Drug Segment by Type
2.2.1 First-Line Anti-Tuberculosis Drugs
2.2.2 Second-Line Anti-Tuberculosis Drugs
2.3 Anti-Tuberculosis Drug Sales by Type
2.3.1 Global Anti-Tuberculosis Drug Sales Market Share by Type (2019-2024)
2.3.2 Global Anti-Tuberculosis Drug Revenue and Market Share by Type (2019-2024)
2.3.3 Global Anti-Tuberculosis Drug Sale Price by Type (2019-2024)
2.4 Anti-Tuberculosis Drug Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Anti-Tuberculosis Drug Sales by Application
2.5.1 Global Anti-Tuberculosis Drug Sale Market Share by Application (2019-2024)
2.5.2 Global Anti-Tuberculosis Drug Revenue and Market Share by Application (2019-2024)
2.5.3 Global Anti-Tuberculosis Drug Sale Price by Application (2019-2024)
3 GLOBAL ANTI-TUBERCULOSIS DRUG BY COMPANY
3.1 Global Anti-Tuberculosis Drug Breakdown Data by Company
3.1.1 Global Anti-Tuberculosis Drug Annual Sales by Company (2019-2024)
3.1.2 Global Anti-Tuberculosis Drug Sales Market Share by Company (2019-2024)
3.2 Global Anti-Tuberculosis Drug Annual Revenue by Company (2019-2024)
3.2.1 Global Anti-Tuberculosis Drug Revenue by Company (2019-2024)
3.2.2 Global Anti-Tuberculosis Drug Revenue Market Share by Company (2019-2024)
3.3 Global Anti-Tuberculosis Drug Sale Price by Company
3.4 Key Manufacturers Anti-Tuberculosis Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Anti-Tuberculosis Drug Product Location Distribution
3.4.2 Players Anti-Tuberculosis Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR ANTI-TUBERCULOSIS DRUG BY GEOGRAPHIC REGION
4.1 World Historic Anti-Tuberculosis Drug Market Size by Geographic Region (2019-2024)
4.1.1 Global Anti-Tuberculosis Drug Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Anti-Tuberculosis Drug Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Anti-Tuberculosis Drug Market Size by Country/Region (2019-2024)
4.2.1 Global Anti-Tuberculosis Drug Annual Sales by Country/Region (2019-2024)
4.2.2 Global Anti-Tuberculosis Drug Annual Revenue by Country/Region (2019-2024)
4.3 Americas Anti-Tuberculosis Drug Sales Growth
4.4 APAC Anti-Tuberculosis Drug Sales Growth
4.5 Europe Anti-Tuberculosis Drug Sales Growth
4.6 Middle East & Africa Anti-Tuberculosis Drug Sales Growth
5 AMERICAS
5.1 Americas Anti-Tuberculosis Drug Sales by Country
5.1.1 Americas Anti-Tuberculosis Drug Sales by Country (2019-2024)
5.1.2 Americas Anti-Tuberculosis Drug Revenue by Country (2019-2024)
5.2 Americas Anti-Tuberculosis Drug Sales by Type
5.3 Americas Anti-Tuberculosis Drug Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Anti-Tuberculosis Drug Sales by Region
6.1.1 APAC Anti-Tuberculosis Drug Sales by Region (2019-2024)
6.1.2 APAC Anti-Tuberculosis Drug Revenue by Region (2019-2024)
6.2 APAC Anti-Tuberculosis Drug Sales by Type
6.3 APAC Anti-Tuberculosis Drug Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Anti-Tuberculosis Drug by Country
7.1.1 Europe Anti-Tuberculosis Drug Sales by Country (2019-2024)
7.1.2 Europe Anti-Tuberculosis Drug Revenue by Country (2019-2024)
7.2 Europe Anti-Tuberculosis Drug Sales by Type
7.3 Europe Anti-Tuberculosis Drug Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Anti-Tuberculosis Drug by Country
8.1.1 Middle East & Africa Anti-Tuberculosis Drug Sales by Country (2019-2024)
8.1.2 Middle East & Africa Anti-Tuberculosis Drug Revenue by Country (2019-2024)
8.2 Middle East & Africa Anti-Tuberculosis Drug Sales by Type
8.3 Middle East & Africa Anti-Tuberculosis Drug Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Anti-Tuberculosis Drug
10.3 Manufacturing Process Analysis of Anti-Tuberculosis Drug
10.4 Industry Chain Structure of Anti-Tuberculosis Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Anti-Tuberculosis Drug Distributors
11.3 Anti-Tuberculosis Drug Customer
12 WORLD FORECAST REVIEW FOR ANTI-TUBERCULOSIS DRUG BY GEOGRAPHIC REGION
12.1 Global Anti-Tuberculosis Drug Market Size Forecast by Region
12.1.1 Global Anti-Tuberculosis Drug Forecast by Region (2025-2030)
12.1.2 Global Anti-Tuberculosis Drug Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Anti-Tuberculosis Drug Forecast by Type
12.7 Global Anti-Tuberculosis Drug Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Lupin
13.1.1 Lupin Company Information
13.1.2 Lupin Anti-Tuberculosis Drug Product Portfolios and Specifications
13.1.3 Lupin Anti-Tuberculosis Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Lupin Main Business Overview
13.1.5 Lupin Latest Developments
13.2 Otsuka
13.2.1 Otsuka Company Information
13.2.2 Otsuka Anti-Tuberculosis Drug Product Portfolios and Specifications
13.2.3 Otsuka Anti-Tuberculosis Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Otsuka Main Business Overview
13.2.5 Otsuka Latest Developments
13.3 Sanofi
13.3.1 Sanofi Company Information
13.3.2 Sanofi Anti-Tuberculosis Drug Product Portfolios and Specifications
13.3.3 Sanofi Anti-Tuberculosis Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Sanofi Main Business Overview
13.3.5 Sanofi Latest Developments
13.4 Prizer
13.4.1 Prizer Company Information
13.4.2 Prizer Anti-Tuberculosis Drug Product Portfolios and Specifications
13.4.3 Prizer Anti-Tuberculosis Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Prizer Main Business Overview
13.4.5 Prizer Latest Developments
13.5 Abbott
13.5.1 Abbott Company Information
13.5.2 Abbott Anti-Tuberculosis Drug Product Portfolios and Specifications
13.5.3 Abbott Anti-Tuberculosis Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Abbott Main Business Overview
13.5.5 Abbott Latest Developments
13.6 NOVARTIS
13.6.1 NOVARTIS Company Information
13.6.2 NOVARTIS Anti-Tuberculosis Drug Product Portfolios and Specifications
13.6.3 NOVARTIS Anti-Tuberculosis Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 NOVARTIS Main Business Overview
13.6.5 NOVARTIS Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Anti-Tuberculosis Drug Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Anti-Tuberculosis Drug by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Anti-Tuberculosis Drug by Country/Region, 2019, 2023 & 2030
2.2 Anti-Tuberculosis Drug Segment by Type
2.2.1 First-Line Anti-Tuberculosis Drugs
2.2.2 Second-Line Anti-Tuberculosis Drugs
2.3 Anti-Tuberculosis Drug Sales by Type
2.3.1 Global Anti-Tuberculosis Drug Sales Market Share by Type (2019-2024)
2.3.2 Global Anti-Tuberculosis Drug Revenue and Market Share by Type (2019-2024)
2.3.3 Global Anti-Tuberculosis Drug Sale Price by Type (2019-2024)
2.4 Anti-Tuberculosis Drug Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Anti-Tuberculosis Drug Sales by Application
2.5.1 Global Anti-Tuberculosis Drug Sale Market Share by Application (2019-2024)
2.5.2 Global Anti-Tuberculosis Drug Revenue and Market Share by Application (2019-2024)
2.5.3 Global Anti-Tuberculosis Drug Sale Price by Application (2019-2024)
3 GLOBAL ANTI-TUBERCULOSIS DRUG BY COMPANY
3.1 Global Anti-Tuberculosis Drug Breakdown Data by Company
3.1.1 Global Anti-Tuberculosis Drug Annual Sales by Company (2019-2024)
3.1.2 Global Anti-Tuberculosis Drug Sales Market Share by Company (2019-2024)
3.2 Global Anti-Tuberculosis Drug Annual Revenue by Company (2019-2024)
3.2.1 Global Anti-Tuberculosis Drug Revenue by Company (2019-2024)
3.2.2 Global Anti-Tuberculosis Drug Revenue Market Share by Company (2019-2024)
3.3 Global Anti-Tuberculosis Drug Sale Price by Company
3.4 Key Manufacturers Anti-Tuberculosis Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Anti-Tuberculosis Drug Product Location Distribution
3.4.2 Players Anti-Tuberculosis Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR ANTI-TUBERCULOSIS DRUG BY GEOGRAPHIC REGION
4.1 World Historic Anti-Tuberculosis Drug Market Size by Geographic Region (2019-2024)
4.1.1 Global Anti-Tuberculosis Drug Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Anti-Tuberculosis Drug Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Anti-Tuberculosis Drug Market Size by Country/Region (2019-2024)
4.2.1 Global Anti-Tuberculosis Drug Annual Sales by Country/Region (2019-2024)
4.2.2 Global Anti-Tuberculosis Drug Annual Revenue by Country/Region (2019-2024)
4.3 Americas Anti-Tuberculosis Drug Sales Growth
4.4 APAC Anti-Tuberculosis Drug Sales Growth
4.5 Europe Anti-Tuberculosis Drug Sales Growth
4.6 Middle East & Africa Anti-Tuberculosis Drug Sales Growth
5 AMERICAS
5.1 Americas Anti-Tuberculosis Drug Sales by Country
5.1.1 Americas Anti-Tuberculosis Drug Sales by Country (2019-2024)
5.1.2 Americas Anti-Tuberculosis Drug Revenue by Country (2019-2024)
5.2 Americas Anti-Tuberculosis Drug Sales by Type
5.3 Americas Anti-Tuberculosis Drug Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Anti-Tuberculosis Drug Sales by Region
6.1.1 APAC Anti-Tuberculosis Drug Sales by Region (2019-2024)
6.1.2 APAC Anti-Tuberculosis Drug Revenue by Region (2019-2024)
6.2 APAC Anti-Tuberculosis Drug Sales by Type
6.3 APAC Anti-Tuberculosis Drug Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Anti-Tuberculosis Drug by Country
7.1.1 Europe Anti-Tuberculosis Drug Sales by Country (2019-2024)
7.1.2 Europe Anti-Tuberculosis Drug Revenue by Country (2019-2024)
7.2 Europe Anti-Tuberculosis Drug Sales by Type
7.3 Europe Anti-Tuberculosis Drug Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Anti-Tuberculosis Drug by Country
8.1.1 Middle East & Africa Anti-Tuberculosis Drug Sales by Country (2019-2024)
8.1.2 Middle East & Africa Anti-Tuberculosis Drug Revenue by Country (2019-2024)
8.2 Middle East & Africa Anti-Tuberculosis Drug Sales by Type
8.3 Middle East & Africa Anti-Tuberculosis Drug Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Anti-Tuberculosis Drug
10.3 Manufacturing Process Analysis of Anti-Tuberculosis Drug
10.4 Industry Chain Structure of Anti-Tuberculosis Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Anti-Tuberculosis Drug Distributors
11.3 Anti-Tuberculosis Drug Customer
12 WORLD FORECAST REVIEW FOR ANTI-TUBERCULOSIS DRUG BY GEOGRAPHIC REGION
12.1 Global Anti-Tuberculosis Drug Market Size Forecast by Region
12.1.1 Global Anti-Tuberculosis Drug Forecast by Region (2025-2030)
12.1.2 Global Anti-Tuberculosis Drug Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Anti-Tuberculosis Drug Forecast by Type
12.7 Global Anti-Tuberculosis Drug Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Lupin
13.1.1 Lupin Company Information
13.1.2 Lupin Anti-Tuberculosis Drug Product Portfolios and Specifications
13.1.3 Lupin Anti-Tuberculosis Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Lupin Main Business Overview
13.1.5 Lupin Latest Developments
13.2 Otsuka
13.2.1 Otsuka Company Information
13.2.2 Otsuka Anti-Tuberculosis Drug Product Portfolios and Specifications
13.2.3 Otsuka Anti-Tuberculosis Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Otsuka Main Business Overview
13.2.5 Otsuka Latest Developments
13.3 Sanofi
13.3.1 Sanofi Company Information
13.3.2 Sanofi Anti-Tuberculosis Drug Product Portfolios and Specifications
13.3.3 Sanofi Anti-Tuberculosis Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Sanofi Main Business Overview
13.3.5 Sanofi Latest Developments
13.4 Prizer
13.4.1 Prizer Company Information
13.4.2 Prizer Anti-Tuberculosis Drug Product Portfolios and Specifications
13.4.3 Prizer Anti-Tuberculosis Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Prizer Main Business Overview
13.4.5 Prizer Latest Developments
13.5 Abbott
13.5.1 Abbott Company Information
13.5.2 Abbott Anti-Tuberculosis Drug Product Portfolios and Specifications
13.5.3 Abbott Anti-Tuberculosis Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Abbott Main Business Overview
13.5.5 Abbott Latest Developments
13.6 NOVARTIS
13.6.1 NOVARTIS Company Information
13.6.2 NOVARTIS Anti-Tuberculosis Drug Product Portfolios and Specifications
13.6.3 NOVARTIS Anti-Tuberculosis Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 NOVARTIS Main Business Overview
13.6.5 NOVARTIS Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Anti-Tuberculosis Drug Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Anti-Tuberculosis Drug Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of First-Line Anti-Tuberculosis Drugs
Table 4. Major Players of Second-Line Anti-Tuberculosis Drugs
Table 5. Global Anti-Tuberculosis Drug Sales by Type (2019-2024) & (K Units)
Table 6. Global Anti-Tuberculosis Drug Sales Market Share by Type (2019-2024)
Table 7. Global Anti-Tuberculosis Drug Revenue by Type (2019-2024) & ($ million)
Table 8. Global Anti-Tuberculosis Drug Revenue Market Share by Type (2019-2024)
Table 9. Global Anti-Tuberculosis Drug Sale Price by Type (2019-2024) & (US$/Unit)
Table 10. Global Anti-Tuberculosis Drug Sales by Application (2019-2024) & (K Units)
Table 11. Global Anti-Tuberculosis Drug Sales Market Share by Application (2019-2024)
Table 12. Global Anti-Tuberculosis Drug Revenue by Application (2019-2024)
Table 13. Global Anti-Tuberculosis Drug Revenue Market Share by Application (2019-2024)
Table 14. Global Anti-Tuberculosis Drug Sale Price by Application (2019-2024) & (US$/Unit)
Table 15. Global Anti-Tuberculosis Drug Sales by Company (2019-2024) & (K Units)
Table 16. Global Anti-Tuberculosis Drug Sales Market Share by Company (2019-2024)
Table 17. Global Anti-Tuberculosis Drug Revenue by Company (2019-2024) ($ Millions)
Table 18. Global Anti-Tuberculosis Drug Revenue Market Share by Company (2019-2024)
Table 19. Global Anti-Tuberculosis Drug Sale Price by Company (2019-2024) & (US$/Unit)
Table 20. Key Manufacturers Anti-Tuberculosis Drug Producing Area Distribution and Sales Area
Table 21. Players Anti-Tuberculosis Drug Products Offered
Table 22. Anti-Tuberculosis Drug Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Anti-Tuberculosis Drug Sales by Geographic Region (2019-2024) & (K Units)
Table 26. Global Anti-Tuberculosis Drug Sales Market Share Geographic Region (2019-2024)
Table 27. Global Anti-Tuberculosis Drug Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Anti-Tuberculosis Drug Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Anti-Tuberculosis Drug Sales by Country/Region (2019-2024) & (K Units)
Table 30. Global Anti-Tuberculosis Drug Sales Market Share by Country/Region (2019-2024)
Table 31. Global Anti-Tuberculosis Drug Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Anti-Tuberculosis Drug Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Anti-Tuberculosis Drug Sales by Country (2019-2024) & (K Units)
Table 34. Americas Anti-Tuberculosis Drug Sales Market Share by Country (2019-2024)
Table 35. Americas Anti-Tuberculosis Drug Revenue by Country (2019-2024) & ($ Millions)
Table 36. Americas Anti-Tuberculosis Drug Revenue Market Share by Country (2019-2024)
Table 37. Americas Anti-Tuberculosis Drug Sales by Type (2019-2024) & (K Units)
Table 38. Americas Anti-Tuberculosis Drug Sales by Application (2019-2024) & (K Units)
Table 39. APAC Anti-Tuberculosis Drug Sales by Region (2019-2024) & (K Units)
Table 40. APAC Anti-Tuberculosis Drug Sales Market Share by Region (2019-2024)
Table 41. APAC Anti-Tuberculosis Drug Revenue by Region (2019-2024) & ($ Millions)
Table 42. APAC Anti-Tuberculosis Drug Revenue Market Share by Region (2019-2024)
Table 43. APAC Anti-Tuberculosis Drug Sales by Type (2019-2024) & (K Units)
Table 44. APAC Anti-Tuberculosis Drug Sales by Application (2019-2024) & (K Units)
Table 45. Europe Anti-Tuberculosis Drug Sales by Country (2019-2024) & (K Units)
Table 46. Europe Anti-Tuberculosis Drug Sales Market Share by Country (2019-2024)
Table 47. Europe Anti-Tuberculosis Drug Revenue by Country (2019-2024) & ($ Millions)
Table 48. Europe Anti-Tuberculosis Drug Revenue Market Share by Country (2019-2024)
Table 49. Europe Anti-Tuberculosis Drug Sales by Type (2019-2024) & (K Units)
Table 50. Europe Anti-Tuberculosis Drug Sales by Application (2019-2024) & (K Units)
Table 51. Middle East & Africa Anti-Tuberculosis Drug Sales by Country (2019-2024) & (K Units)
Table 52. Middle East & Africa Anti-Tuberculosis Drug Sales Market Share by Country (2019-2024)
Table 53. Middle East & Africa Anti-Tuberculosis Drug Revenue by Country (2019-2024) & ($ Millions)
Table 54. Middle East & Africa Anti-Tuberculosis Drug Revenue Market Share by Country (2019-2024)
Table 55. Middle East & Africa Anti-Tuberculosis Drug Sales by Type (2019-2024) & (K Units)
Table 56. Middle East & Africa Anti-Tuberculosis Drug Sales by Application (2019-2024) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Anti-Tuberculosis Drug
Table 58. Key Market Challenges & Risks of Anti-Tuberculosis Drug
Table 59. Key Industry Trends of Anti-Tuberculosis Drug
Table 60. Anti-Tuberculosis Drug Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Anti-Tuberculosis Drug Distributors List
Table 63. Anti-Tuberculosis Drug Customer List
Table 64. Global Anti-Tuberculosis Drug Sales Forecast by Region (2025-2030) & (K Units)
Table 65. Global Anti-Tuberculosis Drug Revenue Forecast by Region (2025-2030) & ($ millions)
Table 66. Americas Anti-Tuberculosis Drug Sales Forecast by Country (2025-2030) & (K Units)
Table 67. Americas Anti-Tuberculosis Drug Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. APAC Anti-Tuberculosis Drug Sales Forecast by Region (2025-2030) & (K Units)
Table 69. APAC Anti-Tuberculosis Drug Revenue Forecast by Region (2025-2030) & ($ millions)
Table 70. Europe Anti-Tuberculosis Drug Sales Forecast by Country (2025-2030) & (K Units)
Table 71. Europe Anti-Tuberculosis Drug Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. Middle East & Africa Anti-Tuberculosis Drug Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Middle East & Africa Anti-Tuberculosis Drug Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Global Anti-Tuberculosis Drug Sales Forecast by Type (2025-2030) & (K Units)
Table 75. Global Anti-Tuberculosis Drug Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 76. Global Anti-Tuberculosis Drug Sales Forecast by Application (2025-2030) & (K Units)
Table 77. Global Anti-Tuberculosis Drug Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 78. Lupin Basic Information, Anti-Tuberculosis Drug Manufacturing Base, Sales Area and Its Competitors
Table 79. Lupin Anti-Tuberculosis Drug Product Portfolios and Specifications
Table 80. Lupin Anti-Tuberculosis Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 81. Lupin Main Business
Table 82. Lupin Latest Developments
Table 83. Otsuka Basic Information, Anti-Tuberculosis Drug Manufacturing Base, Sales Area and Its Competitors
Table 84. Otsuka Anti-Tuberculosis Drug Product Portfolios and Specifications
Table 85. Otsuka Anti-Tuberculosis Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 86. Otsuka Main Business
Table 87. Otsuka Latest Developments
Table 88. Sanofi Basic Information, Anti-Tuberculosis Drug Manufacturing Base, Sales Area and Its Competitors
Table 89. Sanofi Anti-Tuberculosis Drug Product Portfolios and Specifications
Table 90. Sanofi Anti-Tuberculosis Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 91. Sanofi Main Business
Table 92. Sanofi Latest Developments
Table 93. Prizer Basic Information, Anti-Tuberculosis Drug Manufacturing Base, Sales Area and Its Competitors
Table 94. Prizer Anti-Tuberculosis Drug Product Portfolios and Specifications
Table 95. Prizer Anti-Tuberculosis Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 96. Prizer Main Business
Table 97. Prizer Latest Developments
Table 98. Abbott Basic Information, Anti-Tuberculosis Drug Manufacturing Base, Sales Area and Its Competitors
Table 99. Abbott Anti-Tuberculosis Drug Product Portfolios and Specifications
Table 100. Abbott Anti-Tuberculosis Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 101. Abbott Main Business
Table 102. Abbott Latest Developments
Table 103. NOVARTIS Basic Information, Anti-Tuberculosis Drug Manufacturing Base, Sales Area and Its Competitors
Table 104. NOVARTIS Anti-Tuberculosis Drug Product Portfolios and Specifications
Table 105. NOVARTIS Anti-Tuberculosis Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 106. NOVARTIS Main Business
Table 107. NOVARTIS Latest Developments
Table 1. Anti-Tuberculosis Drug Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Anti-Tuberculosis Drug Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of First-Line Anti-Tuberculosis Drugs
Table 4. Major Players of Second-Line Anti-Tuberculosis Drugs
Table 5. Global Anti-Tuberculosis Drug Sales by Type (2019-2024) & (K Units)
Table 6. Global Anti-Tuberculosis Drug Sales Market Share by Type (2019-2024)
Table 7. Global Anti-Tuberculosis Drug Revenue by Type (2019-2024) & ($ million)
Table 8. Global Anti-Tuberculosis Drug Revenue Market Share by Type (2019-2024)
Table 9. Global Anti-Tuberculosis Drug Sale Price by Type (2019-2024) & (US$/Unit)
Table 10. Global Anti-Tuberculosis Drug Sales by Application (2019-2024) & (K Units)
Table 11. Global Anti-Tuberculosis Drug Sales Market Share by Application (2019-2024)
Table 12. Global Anti-Tuberculosis Drug Revenue by Application (2019-2024)
Table 13. Global Anti-Tuberculosis Drug Revenue Market Share by Application (2019-2024)
Table 14. Global Anti-Tuberculosis Drug Sale Price by Application (2019-2024) & (US$/Unit)
Table 15. Global Anti-Tuberculosis Drug Sales by Company (2019-2024) & (K Units)
Table 16. Global Anti-Tuberculosis Drug Sales Market Share by Company (2019-2024)
Table 17. Global Anti-Tuberculosis Drug Revenue by Company (2019-2024) ($ Millions)
Table 18. Global Anti-Tuberculosis Drug Revenue Market Share by Company (2019-2024)
Table 19. Global Anti-Tuberculosis Drug Sale Price by Company (2019-2024) & (US$/Unit)
Table 20. Key Manufacturers Anti-Tuberculosis Drug Producing Area Distribution and Sales Area
Table 21. Players Anti-Tuberculosis Drug Products Offered
Table 22. Anti-Tuberculosis Drug Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Anti-Tuberculosis Drug Sales by Geographic Region (2019-2024) & (K Units)
Table 26. Global Anti-Tuberculosis Drug Sales Market Share Geographic Region (2019-2024)
Table 27. Global Anti-Tuberculosis Drug Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Anti-Tuberculosis Drug Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Anti-Tuberculosis Drug Sales by Country/Region (2019-2024) & (K Units)
Table 30. Global Anti-Tuberculosis Drug Sales Market Share by Country/Region (2019-2024)
Table 31. Global Anti-Tuberculosis Drug Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Anti-Tuberculosis Drug Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Anti-Tuberculosis Drug Sales by Country (2019-2024) & (K Units)
Table 34. Americas Anti-Tuberculosis Drug Sales Market Share by Country (2019-2024)
Table 35. Americas Anti-Tuberculosis Drug Revenue by Country (2019-2024) & ($ Millions)
Table 36. Americas Anti-Tuberculosis Drug Revenue Market Share by Country (2019-2024)
Table 37. Americas Anti-Tuberculosis Drug Sales by Type (2019-2024) & (K Units)
Table 38. Americas Anti-Tuberculosis Drug Sales by Application (2019-2024) & (K Units)
Table 39. APAC Anti-Tuberculosis Drug Sales by Region (2019-2024) & (K Units)
Table 40. APAC Anti-Tuberculosis Drug Sales Market Share by Region (2019-2024)
Table 41. APAC Anti-Tuberculosis Drug Revenue by Region (2019-2024) & ($ Millions)
Table 42. APAC Anti-Tuberculosis Drug Revenue Market Share by Region (2019-2024)
Table 43. APAC Anti-Tuberculosis Drug Sales by Type (2019-2024) & (K Units)
Table 44. APAC Anti-Tuberculosis Drug Sales by Application (2019-2024) & (K Units)
Table 45. Europe Anti-Tuberculosis Drug Sales by Country (2019-2024) & (K Units)
Table 46. Europe Anti-Tuberculosis Drug Sales Market Share by Country (2019-2024)
Table 47. Europe Anti-Tuberculosis Drug Revenue by Country (2019-2024) & ($ Millions)
Table 48. Europe Anti-Tuberculosis Drug Revenue Market Share by Country (2019-2024)
Table 49. Europe Anti-Tuberculosis Drug Sales by Type (2019-2024) & (K Units)
Table 50. Europe Anti-Tuberculosis Drug Sales by Application (2019-2024) & (K Units)
Table 51. Middle East & Africa Anti-Tuberculosis Drug Sales by Country (2019-2024) & (K Units)
Table 52. Middle East & Africa Anti-Tuberculosis Drug Sales Market Share by Country (2019-2024)
Table 53. Middle East & Africa Anti-Tuberculosis Drug Revenue by Country (2019-2024) & ($ Millions)
Table 54. Middle East & Africa Anti-Tuberculosis Drug Revenue Market Share by Country (2019-2024)
Table 55. Middle East & Africa Anti-Tuberculosis Drug Sales by Type (2019-2024) & (K Units)
Table 56. Middle East & Africa Anti-Tuberculosis Drug Sales by Application (2019-2024) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Anti-Tuberculosis Drug
Table 58. Key Market Challenges & Risks of Anti-Tuberculosis Drug
Table 59. Key Industry Trends of Anti-Tuberculosis Drug
Table 60. Anti-Tuberculosis Drug Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Anti-Tuberculosis Drug Distributors List
Table 63. Anti-Tuberculosis Drug Customer List
Table 64. Global Anti-Tuberculosis Drug Sales Forecast by Region (2025-2030) & (K Units)
Table 65. Global Anti-Tuberculosis Drug Revenue Forecast by Region (2025-2030) & ($ millions)
Table 66. Americas Anti-Tuberculosis Drug Sales Forecast by Country (2025-2030) & (K Units)
Table 67. Americas Anti-Tuberculosis Drug Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. APAC Anti-Tuberculosis Drug Sales Forecast by Region (2025-2030) & (K Units)
Table 69. APAC Anti-Tuberculosis Drug Revenue Forecast by Region (2025-2030) & ($ millions)
Table 70. Europe Anti-Tuberculosis Drug Sales Forecast by Country (2025-2030) & (K Units)
Table 71. Europe Anti-Tuberculosis Drug Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. Middle East & Africa Anti-Tuberculosis Drug Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Middle East & Africa Anti-Tuberculosis Drug Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Global Anti-Tuberculosis Drug Sales Forecast by Type (2025-2030) & (K Units)
Table 75. Global Anti-Tuberculosis Drug Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 76. Global Anti-Tuberculosis Drug Sales Forecast by Application (2025-2030) & (K Units)
Table 77. Global Anti-Tuberculosis Drug Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 78. Lupin Basic Information, Anti-Tuberculosis Drug Manufacturing Base, Sales Area and Its Competitors
Table 79. Lupin Anti-Tuberculosis Drug Product Portfolios and Specifications
Table 80. Lupin Anti-Tuberculosis Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 81. Lupin Main Business
Table 82. Lupin Latest Developments
Table 83. Otsuka Basic Information, Anti-Tuberculosis Drug Manufacturing Base, Sales Area and Its Competitors
Table 84. Otsuka Anti-Tuberculosis Drug Product Portfolios and Specifications
Table 85. Otsuka Anti-Tuberculosis Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 86. Otsuka Main Business
Table 87. Otsuka Latest Developments
Table 88. Sanofi Basic Information, Anti-Tuberculosis Drug Manufacturing Base, Sales Area and Its Competitors
Table 89. Sanofi Anti-Tuberculosis Drug Product Portfolios and Specifications
Table 90. Sanofi Anti-Tuberculosis Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 91. Sanofi Main Business
Table 92. Sanofi Latest Developments
Table 93. Prizer Basic Information, Anti-Tuberculosis Drug Manufacturing Base, Sales Area and Its Competitors
Table 94. Prizer Anti-Tuberculosis Drug Product Portfolios and Specifications
Table 95. Prizer Anti-Tuberculosis Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 96. Prizer Main Business
Table 97. Prizer Latest Developments
Table 98. Abbott Basic Information, Anti-Tuberculosis Drug Manufacturing Base, Sales Area and Its Competitors
Table 99. Abbott Anti-Tuberculosis Drug Product Portfolios and Specifications
Table 100. Abbott Anti-Tuberculosis Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 101. Abbott Main Business
Table 102. Abbott Latest Developments
Table 103. NOVARTIS Basic Information, Anti-Tuberculosis Drug Manufacturing Base, Sales Area and Its Competitors
Table 104. NOVARTIS Anti-Tuberculosis Drug Product Portfolios and Specifications
Table 105. NOVARTIS Anti-Tuberculosis Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 106. NOVARTIS Main Business
Table 107. NOVARTIS Latest Developments
LIST OF FIGURES
Figure 1. Picture of Anti-Tuberculosis Drug
Figure 2. Anti-Tuberculosis Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Anti-Tuberculosis Drug Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Anti-Tuberculosis Drug Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Anti-Tuberculosis Drug Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of First-Line Anti-Tuberculosis Drugs
Figure 10. Product Picture of Second-Line Anti-Tuberculosis Drugs
Figure 11. Global Anti-Tuberculosis Drug Sales Market Share by Type in 2023
Figure 12. Global Anti-Tuberculosis Drug Revenue Market Share by Type (2019-2024)
Figure 13. Anti-Tuberculosis Drug Consumed in Hospital
Figure 14. Global Anti-Tuberculosis Drug Market: Hospital (2019-2024) & (K Units)
Figure 15. Anti-Tuberculosis Drug Consumed in Clinic
Figure 16. Global Anti-Tuberculosis Drug Market: Clinic (2019-2024) & (K Units)
Figure 17. Anti-Tuberculosis Drug Consumed in Others
Figure 18. Global Anti-Tuberculosis Drug Market: Others (2019-2024) & (K Units)
Figure 19. Global Anti-Tuberculosis Drug Sales Market Share by Application (2023)
Figure 20. Global Anti-Tuberculosis Drug Revenue Market Share by Application in 2023
Figure 21. Anti-Tuberculosis Drug Sales Market by Company in 2023 (K Units)
Figure 22. Global Anti-Tuberculosis Drug Sales Market Share by Company in 2023
Figure 23. Anti-Tuberculosis Drug Revenue Market by Company in 2023 ($ Million)
Figure 24. Global Anti-Tuberculosis Drug Revenue Market Share by Company in 2023
Figure 25. Global Anti-Tuberculosis Drug Sales Market Share by Geographic Region (2019-2024)
Figure 26. Global Anti-Tuberculosis Drug Revenue Market Share by Geographic Region in 2023
Figure 27. Americas Anti-Tuberculosis Drug Sales 2019-2024 (K Units)
Figure 28. Americas Anti-Tuberculosis Drug Revenue 2019-2024 ($ Millions)
Figure 29. APAC Anti-Tuberculosis Drug Sales 2019-2024 (K Units)
Figure 30. APAC Anti-Tuberculosis Drug Revenue 2019-2024 ($ Millions)
Figure 31. Europe Anti-Tuberculosis Drug Sales 2019-2024 (K Units)
Figure 32. Europe Anti-Tuberculosis Drug Revenue 2019-2024 ($ Millions)
Figure 33. Middle East & Africa Anti-Tuberculosis Drug Sales 2019-2024 (K Units)
Figure 34. Middle East & Africa Anti-Tuberculosis Drug Revenue 2019-2024 ($ Millions)
Figure 35. Americas Anti-Tuberculosis Drug Sales Market Share by Country in 2023
Figure 36. Americas Anti-Tuberculosis Drug Revenue Market Share by Country in 2023
Figure 37. Americas Anti-Tuberculosis Drug Sales Market Share by Type (2019-2024)
Figure 38. Americas Anti-Tuberculosis Drug Sales Market Share by Application (2019-2024)
Figure 39. United States Anti-Tuberculosis Drug Revenue Growth 2019-2024 ($ Millions)
Figure 40. Canada Anti-Tuberculosis Drug Revenue Growth 2019-2024 ($ Millions)
Figure 41. Mexico Anti-Tuberculosis Drug Revenue Growth 2019-2024 ($ Millions)
Figure 42. Brazil Anti-Tuberculosis Drug Revenue Growth 2019-2024 ($ Millions)
Figure 43. APAC Anti-Tuberculosis Drug Sales Market Share by Region in 2023
Figure 44. APAC Anti-Tuberculosis Drug Revenue Market Share by Regions in 2023
Figure 45. APAC Anti-Tuberculosis Drug Sales Market Share by Type (2019-2024)
Figure 46. APAC Anti-Tuberculosis Drug Sales Market Share by Application (2019-2024)
Figure 47. China Anti-Tuberculosis Drug Revenue Growth 2019-2024 ($ Millions)
Figure 48. Japan Anti-Tuberculosis Drug Revenue Growth 2019-2024 ($ Millions)
Figure 49. South Korea Anti-Tuberculosis Drug Revenue Growth 2019-2024 ($ Millions)
Figure 50. Southeast Asia Anti-Tuberculosis Drug Revenue Growth 2019-2024 ($ Millions)
Figure 51. India Anti-Tuberculosis Drug Revenue Growth 2019-2024 ($ Millions)
Figure 52. Australia Anti-Tuberculosis Drug Revenue Growth 2019-2024 ($ Millions)
Figure 53. China Taiwan Anti-Tuberculosis Drug Revenue Growth 2019-2024 ($ Millions)
Figure 54. Europe Anti-Tuberculosis Drug Sales Market Share by Country in 2023
Figure 55. Europe Anti-Tuberculosis Drug Revenue Market Share by Country in 2023
Figure 56. Europe Anti-Tuberculosis Drug Sales Market Share by Type (2019-2024)
Figure 57. Europe Anti-Tuberculosis Drug Sales Market Share by Application (2019-2024)
Figure 58. Germany Anti-Tuberculosis Drug Revenue Growth 2019-2024 ($ Millions)
Figure 59. France Anti-Tuberculosis Drug Revenue Growth 2019-2024 ($ Millions)
Figure 60. UK Anti-Tuberculosis Drug Revenue Growth 2019-2024 ($ Millions)
Figure 61. Italy Anti-Tuberculosis Drug Revenue Growth 2019-2024 ($ Millions)
Figure 62. Russia Anti-Tuberculosis Drug Revenue Growth 2019-2024 ($ Millions)
Figure 63. Middle East & Africa Anti-Tuberculosis Drug Sales Market Share by Country in 2023
Figure 64. Middle East & Africa Anti-Tuberculosis Drug Revenue Market Share by Country in 2023
Figure 65. Middle East & Africa Anti-Tuberculosis Drug Sales Market Share by Type (2019-2024)
Figure 66. Middle East & Africa Anti-Tuberculosis Drug Sales Market Share by Application (2019-2024)
Figure 67. Egypt Anti-Tuberculosis Drug Revenue Growth 2019-2024 ($ Millions)
Figure 68. South Africa Anti-Tuberculosis Drug Revenue Growth 2019-2024 ($ Millions)
Figure 69. Israel Anti-Tuberculosis Drug Revenue Growth 2019-2024 ($ Millions)
Figure 70. Turkey Anti-Tuberculosis Drug Revenue Growth 2019-2024 ($ Millions)
Figure 71. GCC Country Anti-Tuberculosis Drug Revenue Growth 2019-2024 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Anti-Tuberculosis Drug in 2023
Figure 73. Manufacturing Process Analysis of Anti-Tuberculosis Drug
Figure 74. Industry Chain Structure of Anti-Tuberculosis Drug
Figure 75. Channels of Distribution
Figure 76. Global Anti-Tuberculosis Drug Sales Market Forecast by Region (2025-2030)
Figure 77. Global Anti-Tuberculosis Drug Revenue Market Share Forecast by Region (2025-2030)
Figure 78. Global Anti-Tuberculosis Drug Sales Market Share Forecast by Type (2025-2030)
Figure 79. Global Anti-Tuberculosis Drug Revenue Market Share Forecast by Type (2025-2030)
Figure 80. Global Anti-Tuberculosis Drug Sales Market Share Forecast by Application (2025-2030)
Figure 81. Global Anti-Tuberculosis Drug Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Anti-Tuberculosis Drug
Figure 2. Anti-Tuberculosis Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Anti-Tuberculosis Drug Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Anti-Tuberculosis Drug Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Anti-Tuberculosis Drug Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of First-Line Anti-Tuberculosis Drugs
Figure 10. Product Picture of Second-Line Anti-Tuberculosis Drugs
Figure 11. Global Anti-Tuberculosis Drug Sales Market Share by Type in 2023
Figure 12. Global Anti-Tuberculosis Drug Revenue Market Share by Type (2019-2024)
Figure 13. Anti-Tuberculosis Drug Consumed in Hospital
Figure 14. Global Anti-Tuberculosis Drug Market: Hospital (2019-2024) & (K Units)
Figure 15. Anti-Tuberculosis Drug Consumed in Clinic
Figure 16. Global Anti-Tuberculosis Drug Market: Clinic (2019-2024) & (K Units)
Figure 17. Anti-Tuberculosis Drug Consumed in Others
Figure 18. Global Anti-Tuberculosis Drug Market: Others (2019-2024) & (K Units)
Figure 19. Global Anti-Tuberculosis Drug Sales Market Share by Application (2023)
Figure 20. Global Anti-Tuberculosis Drug Revenue Market Share by Application in 2023
Figure 21. Anti-Tuberculosis Drug Sales Market by Company in 2023 (K Units)
Figure 22. Global Anti-Tuberculosis Drug Sales Market Share by Company in 2023
Figure 23. Anti-Tuberculosis Drug Revenue Market by Company in 2023 ($ Million)
Figure 24. Global Anti-Tuberculosis Drug Revenue Market Share by Company in 2023
Figure 25. Global Anti-Tuberculosis Drug Sales Market Share by Geographic Region (2019-2024)
Figure 26. Global Anti-Tuberculosis Drug Revenue Market Share by Geographic Region in 2023
Figure 27. Americas Anti-Tuberculosis Drug Sales 2019-2024 (K Units)
Figure 28. Americas Anti-Tuberculosis Drug Revenue 2019-2024 ($ Millions)
Figure 29. APAC Anti-Tuberculosis Drug Sales 2019-2024 (K Units)
Figure 30. APAC Anti-Tuberculosis Drug Revenue 2019-2024 ($ Millions)
Figure 31. Europe Anti-Tuberculosis Drug Sales 2019-2024 (K Units)
Figure 32. Europe Anti-Tuberculosis Drug Revenue 2019-2024 ($ Millions)
Figure 33. Middle East & Africa Anti-Tuberculosis Drug Sales 2019-2024 (K Units)
Figure 34. Middle East & Africa Anti-Tuberculosis Drug Revenue 2019-2024 ($ Millions)
Figure 35. Americas Anti-Tuberculosis Drug Sales Market Share by Country in 2023
Figure 36. Americas Anti-Tuberculosis Drug Revenue Market Share by Country in 2023
Figure 37. Americas Anti-Tuberculosis Drug Sales Market Share by Type (2019-2024)
Figure 38. Americas Anti-Tuberculosis Drug Sales Market Share by Application (2019-2024)
Figure 39. United States Anti-Tuberculosis Drug Revenue Growth 2019-2024 ($ Millions)
Figure 40. Canada Anti-Tuberculosis Drug Revenue Growth 2019-2024 ($ Millions)
Figure 41. Mexico Anti-Tuberculosis Drug Revenue Growth 2019-2024 ($ Millions)
Figure 42. Brazil Anti-Tuberculosis Drug Revenue Growth 2019-2024 ($ Millions)
Figure 43. APAC Anti-Tuberculosis Drug Sales Market Share by Region in 2023
Figure 44. APAC Anti-Tuberculosis Drug Revenue Market Share by Regions in 2023
Figure 45. APAC Anti-Tuberculosis Drug Sales Market Share by Type (2019-2024)
Figure 46. APAC Anti-Tuberculosis Drug Sales Market Share by Application (2019-2024)
Figure 47. China Anti-Tuberculosis Drug Revenue Growth 2019-2024 ($ Millions)
Figure 48. Japan Anti-Tuberculosis Drug Revenue Growth 2019-2024 ($ Millions)
Figure 49. South Korea Anti-Tuberculosis Drug Revenue Growth 2019-2024 ($ Millions)
Figure 50. Southeast Asia Anti-Tuberculosis Drug Revenue Growth 2019-2024 ($ Millions)
Figure 51. India Anti-Tuberculosis Drug Revenue Growth 2019-2024 ($ Millions)
Figure 52. Australia Anti-Tuberculosis Drug Revenue Growth 2019-2024 ($ Millions)
Figure 53. China Taiwan Anti-Tuberculosis Drug Revenue Growth 2019-2024 ($ Millions)
Figure 54. Europe Anti-Tuberculosis Drug Sales Market Share by Country in 2023
Figure 55. Europe Anti-Tuberculosis Drug Revenue Market Share by Country in 2023
Figure 56. Europe Anti-Tuberculosis Drug Sales Market Share by Type (2019-2024)
Figure 57. Europe Anti-Tuberculosis Drug Sales Market Share by Application (2019-2024)
Figure 58. Germany Anti-Tuberculosis Drug Revenue Growth 2019-2024 ($ Millions)
Figure 59. France Anti-Tuberculosis Drug Revenue Growth 2019-2024 ($ Millions)
Figure 60. UK Anti-Tuberculosis Drug Revenue Growth 2019-2024 ($ Millions)
Figure 61. Italy Anti-Tuberculosis Drug Revenue Growth 2019-2024 ($ Millions)
Figure 62. Russia Anti-Tuberculosis Drug Revenue Growth 2019-2024 ($ Millions)
Figure 63. Middle East & Africa Anti-Tuberculosis Drug Sales Market Share by Country in 2023
Figure 64. Middle East & Africa Anti-Tuberculosis Drug Revenue Market Share by Country in 2023
Figure 65. Middle East & Africa Anti-Tuberculosis Drug Sales Market Share by Type (2019-2024)
Figure 66. Middle East & Africa Anti-Tuberculosis Drug Sales Market Share by Application (2019-2024)
Figure 67. Egypt Anti-Tuberculosis Drug Revenue Growth 2019-2024 ($ Millions)
Figure 68. South Africa Anti-Tuberculosis Drug Revenue Growth 2019-2024 ($ Millions)
Figure 69. Israel Anti-Tuberculosis Drug Revenue Growth 2019-2024 ($ Millions)
Figure 70. Turkey Anti-Tuberculosis Drug Revenue Growth 2019-2024 ($ Millions)
Figure 71. GCC Country Anti-Tuberculosis Drug Revenue Growth 2019-2024 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Anti-Tuberculosis Drug in 2023
Figure 73. Manufacturing Process Analysis of Anti-Tuberculosis Drug
Figure 74. Industry Chain Structure of Anti-Tuberculosis Drug
Figure 75. Channels of Distribution
Figure 76. Global Anti-Tuberculosis Drug Sales Market Forecast by Region (2025-2030)
Figure 77. Global Anti-Tuberculosis Drug Revenue Market Share Forecast by Region (2025-2030)
Figure 78. Global Anti-Tuberculosis Drug Sales Market Share Forecast by Type (2025-2030)
Figure 79. Global Anti-Tuberculosis Drug Revenue Market Share Forecast by Type (2025-2030)
Figure 80. Global Anti-Tuberculosis Drug Sales Market Share Forecast by Application (2025-2030)
Figure 81. Global Anti-Tuberculosis Drug Revenue Market Share Forecast by Application (2025-2030)
